Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018” report has been added to ResearchAndMarkets.com’s offering.
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012-2018 report.
The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors product or technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This report contains a comprehensive listing of all discovery stage partnering deals announced since 2012 including financial terms where available including over 3,000 links to online deal records of actual discovery partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Key benefitsIn-depth understanding of discovery stage deal trends since 2012 Access to headline, upfront, milestone and royalty data Analysis of the structure of discovery stage agreements with numerous real life case studies Insight into the terms included in a discovery stage agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Available contracts are listed by:Company A-Z Headline value Stage of development at signing Deal type Specific therapy target
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Why do companies partner at discovery stage?
Chapter 3 - Discovery stage deal strategies and structure
Chapter 4 - Discovery stage partnering payment strategies
Chapter 5 - Trends in discovery stage deal making
Chapter 6 - Payment terms for discovery stage partnering
Chapter 7 - Leading discovery stage deals
Chapter 8 - Top 50 most active discovery stage dealmakers
Chapter 9 - Discovery stage partnering contracts directory
Chapter 10 - Discovery stage deal making by development stage
For more information about this report visit https://www.researchandmarkets.com/research/fcg64f/global_discovery?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180611005898/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Biotechnology,Pharmaceuticals,Drug Discovery
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/11/2018 12:51 PM/DISC: 06/11/2018 12:51 PM